🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
8.25
-0.35 (-4.07%)
Nov 19, 2026, 11:10 AM EST

COSCIENS Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9.767.59.597.1414.575.26
Revenue Growth
13.35%-21.79%34.22%-50.98%177.03%44.03%
Cost of Revenue
4.954.934.864.216.020.09
Gross Profit
4.812.574.732.948.565.17
Selling, General & Admin
8.3310.066.375.532.877.27
Research & Development
1.962.958.32.041.376.57
Operating Expenses
10.2813.0114.677.574.2413.84
Operating Income
-5.47-10.44-9.94-4.634.32-8.67
Interest Expense
-0.25-0.17-0.13-0.14-0.14-0.01
Interest & Investment Income
0.10.280.440.060.15-
Currency Exchange Gain (Loss)
0.13-0.20.05-0.020.210.22
Other Non Operating Income (Expenses)
0.130.412.70.36-0.01-0.01
EBT Excluding Unusual Items
-5.37-10.11-6.89-4.374.53-8.48
Merger & Restructuring Charges
---4.08---
Asset Writedown
-2.04-0.24-4.26---
Pretax Income
-7.41-10.35-15.23-4.374.53-8.48
Income Tax Expense
0.010.010.08-0.891.08-0.11
Earnings From Continuing Operations
-7.42-10.36-15.31-3.493.45-8.37
Earnings From Discontinued Operations
12.35-----
Net Income
4.93-10.36-15.31-3.493.45-8.37
Net Income to Common
4.93-10.36-15.31-3.493.45-8.37
Net Income Growth
------
Shares Outstanding (Basic)
111110
Shares Outstanding (Diluted)
111110
Shares Change
13.98%22.62%39.74%-0.39%61.37%179.74%
EPS (Basic)
4.72-9.82-17.79-5.665.62-21.84
EPS (Diluted)
4.72-9.82-17.79-5.675.58-21.84
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.67-9.18-15.73-3.34.93-8.61
Free Cash Flow Per Share
-1.40-8.70-18.28-5.377.97-22.48
Gross Margin
49.32%34.29%49.33%41.13%58.71%98.29%
Operating Margin
-56.05%-139.25%-103.70%-64.81%29.65%-164.85%
Profit Margin
50.52%-138.14%-159.69%-48.79%23.66%-159.09%
Free Cash Flow Margin
-17.14%-122.42%-164.07%-46.26%33.80%-163.71%
EBITDA
-4.46-9.52-8.68-3.195.79-8.53
EBITDA Margin
-45.74%-126.90%-90.52%-44.60%39.72%-162.09%
D&A For EBITDA
1.010.931.261.441.470.15
EBIT
-5.47-10.44-9.94-4.634.32-8.67
EBIT Margin
-56.05%-139.25%-103.70%-64.81%29.65%-164.85%
Effective Tax Rate
----23.85%-